China National Medicines Corporation Ltd.
Shanghai Stock Exchange:600511.SS
Sector
Location
Market Cap
USD 3.13 B
Share Price
USD 4.15
Avg Daily Volume
4,571,420
Change (1 day)
0.27%
Change (1 year)
-12.72%
Change (YTD)
-11.49%
China National Medicines Corporation Ltd. Income Statement 2014 - 2024
This table shows the Income Statement for China National Medicines Corporation Ltd. going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Cardinal Health, Inc.
USD 157.41
CAH
+4.00
2.61%
EBOS Group Limited
USD 24.49
EBO.AX
-0.27
-1.07%
Mouwasat Medical Services Company
USD 20.77
4002.SR
+0.41
2.02%
Dallah Healthcare Company
USD 36.50
4004.SR
+0.34
0.95%
MediPal Holdings Corporation
USD 17.49
7459.T
-0.09
-0.48%
Suzuken Co., Ltd.
USD 40.64
9987.T
+0.61
1.52%
KPJ Healthcare Berhad
USD 0.67
5878.KL
+0.01
1.83%
Alfresa Holdings Corporation
USD 15.28
2784.T
+0.20
1.32%
Dr. Soliman Abdel Kader Fakeeh Hospital Company
USD 10.97
4017.SR
+0.06
0.58%
Toho Holdings Co., Ltd.
USD 36.46
8129.T
+0.50
1.38%
China Meheco Group Co., Ltd.
USD 1.51
600056.SS
+0.00
0.15%
Al Hammadi Company For Development and Investment
USD 9.28
4007.SR
-0.43
-4.45%
Johnson & Johnson
USD 173.33
JNJ
+1.80
1.05%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
Abbott Laboratories
USD 134.28
ABT
+2.22
1.68%